Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution
May 10, 2021 07:00 ET | Vineti
New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced therapy clinical...
Global $6.56 Billion Regenerative Medicine for Cartilage Markets, 2015-2020, 2020-2025F, 2030F
May 07, 2021 04:08 ET | Research and Markets
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Regenerative Medicine for Cartilage Global Market Report 2021: COVID-19 Growth and Change" report has been added to's...
Bone Therapeutics to host Annual General Meeting on 9 June 2021
May 07, 2021 01:00 ET | Bone Therapeutics SA
REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s website Gosselies, Belgium, 7 May 2021, 7am CEST – BONE THERAPEUTICS (Euronext...
Bone Therapeutics tiendra son Assemblée Générale Ordinaire le 9 juin 2021
May 07, 2021 01:00 ET | Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Mise à disposition des documents préparatoires à l’assemblée générale ordinaire sur le site internet de la Société Gosselies, Belgique, le 7 mai 2021 à...
Talaris Therapeutics Announces Pricing of Initial Public Offering
May 06, 2021 21:53 ET | Talaris Therapeutics, Inc.
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing therapies with the potential to transform the standard...
Bone Therapeutics announces 2020 full year results
April 29, 2021 01:00 ET | Bone Therapeutics SA
REGULATED INFORMATION   Ongoing clinical progress across pipeline, including Phase III and IIb clinical trials Multiple new collaborations and partnerships to enhance development, manufacturing...
Bone Therapeutics publie ses résultats annuels 2020
April 29, 2021 01:00 ET | Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Fortes avancées cliniques sur l’ensemble du portefeuille de produits, dont les essais cliniques de Phase IIb et III Mise en place de nouvelles collaborations et...
Stanley R. Frankel, MD, FACP joins Cytovia Therapeutics as Chief Medical Officer
April 28, 2021 13:16 ET | Cytovia Therapeutics
CAMBRIDGE, Mass. and AVENTURA, Fla., April 28, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Chimeric Antigen...
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
April 27, 2021 16:35 ET | Sana Biotechnology, Inc
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including T cells and hepatocytes — SEATTLE, April 27, 2021 (GLOBE NEWSWIRE)...
Adaptimmune logo Colour_white background_no strap.jpg
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
April 27, 2021 16:30 ET | Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report initial preclinical...